Supplier
Amber Enterprises INC
Amber Enterprises INC was paid $2K by Medicaid between Apr 2018 and Nov 2023, across 6 billing codes. Its largest line is J7503, Tacrolimus, extended release, (envarsus xr), oral, 0.25 mg — 47% of everything it billed.
33Billing provider infoAMBER ENTERPRISES INC
AMBLER, PA 19002
AMBLER, PA 19002
33aNPI1275598146assigned 04/20/2006
33bProvider typeDurable Medical Equipment & Medical Supplies
28Total paid$2K
24GClaims4,107
24DCodes billed6
24AFirst – last monthApr 2018 – Nov 2023
Compared with peers
Next to other Durable Medical Equipment & Medical Supplies providers in Pennsylvania
Rank by total paid#251 of 279
Median peer was paid$181K
This provider vs. median0.0×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 794 | $78.03 | |
| 2019 | 665 | $436.16 | |
| 2020 | 515 | $4.53 | |
| 2021 | 1,163 | $305.88 | |
| 2022 | 667 | $738.68 | |
| 2023 | 303 | $60.40 |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| J7503 | Tacrolimus, extended release, (envarsus xr), oral, 0.25 mg | 47% | 321 | 190 | $765.33 |
| J7507 | Tacrolimus, immediate release, oral, 1 mg | 31% | 360 | 317 | $500.41 |
| Q0511 | Pharmacy supply fee for oral anti-cancer, oral anti-emetic or immunosuppressive drug(s); for the first prescription in a 30-day period | 9.4% | 1,045 | 930 | $152.91 |
| Q0512 | Pharmacy supply fee for oral anti-cancer, oral anti-emetic or immunosuppressive drug(s); for a subsequent prescription in a 30-day period | 9.1% | 1,980 | 1,130 | $148.49 |
| J7517 | Mycophenolate mofetil, oral, 250 mg | 2.4% | 181 | 159 | $39.44 |
| J7512 | Prednisone, immediate release or delayed release, oral, 1 mg | 1.1% | 220 | 203 | $17.10 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialWILLIAMS, KRISTIN (PRESIDENT)
Parent organizationAMBER ACQUISITION, LLC
| Provider | Location | Paid |
|---|---|---|
| Amber Enterprises INC. | Omaha, NE | $2.35M |
| Hyvacs, LLC | Omaha, NE | $1.12M |
| Amber Enterprises INC | Richardson, TX | $79K |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.